【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1556次   下载 2904 本文二维码信息
码上扫一扫!
膀胱癌分子分型的研究进展
王凯剑,戴利和,许传亮*
0
(第二军医大学长海医院泌尿外科, 上海 200433
*通信作者)
摘要:
膀胱癌是一种严重危害人类健康的恶性肿瘤,但其诊治进展较为缓慢。随着分子生物学的快速发展和生物检测技术的不断涌现,通过基因分析技术对膀胱癌进行分子分型有望成为提高膀胱癌诊治水平的重要手段。本文就近年来膀胱癌分子分型的研究进展以及膀胱癌分子分型对预测药物反应性和判断预后的临床价值作一综述。
关键词:  膀胱癌  分子分型  基因分析  预后  耐药性
DOI:10.16781/j.0258-879x.2018.01.0081
投稿时间:2017-09-22修订日期:2017-11-06
基金项目:
Molecular typing of bladder cancer: an update
WANG Kai-jian,DAI Li-he,XU Chuan-liang*
(Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
*Corresponding author)
Abstract:
Bladder cancer is one of the malignant tumors that seriously endanger human health, but its diagnosis and treatment progress are relatively slow. With the rapid development of molecular biology and the continuous emergence of biological detection technology, the molecular typing of bladder cancer through gene analysis is expected to become an important means to improve the diagnosis and treatment of bladder cancer. In this paper, we summarized the recent advances in the molecular typing of bladder cancer and its clinical significance in predicting drug responsiveness and judging prognosis.
Key words:  bladder carcinoma  molecular typing  gene analysis  prognosis  drug resistance